Archive

FDA Inspects Specialty Compounding Pharmacies

  • March 25, 2013
  • Pharmaceutical Litigation
  • 0 Comments
As reported by The Washington Post, federal regulators are in the process of conducting unannounced inspections of specialty pharmacies.  Those pharmacies have been in the spotlight since a fall 2012 outbreak of meningitis had been linked to tainted drugs. Two manufacturing-style compounding pharmacies already inspected were a part of a prior Washington Post investigation.  The
Read More

Arguments Heard Regarding Formation of MDL on Pradaxa Lawsuits

  • August 8, 2012
  • Pharmaceutical Litigation
  • 0 Comments
As reported by The Legal Examiner, the U.S. Judicial Panel on Multidistrict Litigation (JPML) heard oral arguments on July 26 regarding the formation of the Pradaxa MDL, or multidistrict litigation. The hearing was held at Carl B. Stokes U.S. Courthouse in Cleveland, OH. Multidistrict litigation is common in complex pharmaceutical litigation where a large number
Read More

Drug Maker GlaxoSmithKline to Pay $3 Billion in Health Fraud Case

  • July 16, 2012
  • Pharmaceutical Litigation
  • 0 Comments
British drug manufacturer GlaxoSmithKline (GSK) has been ordered to pay $3 billion for criminal and civil violations involving ten drugs, as reported by Fox News. The $3 billion marks the largest health care fraud settlement in U.S. history, and GlaxoSmithKline has pled guilty to promoting Paxil and Wellbutrin, two popular antidepressants, for unapproved uses. According
Read More

Diabetes Drug Avandia Could Be Pulled from Market

  • July 27, 2010
  • Pharmaceutical Litigation
  • 0 Comments
On June 28, a study was released which showed a connection between Avandia, a diabetes drug made by GlaxoSmithKline, and increased risks of heart problems, strokes and deaths in older adults. According to FoxNews.com, the study conducted a comprehensive review of over 200,000 Medicare patients who took Avandia. The study followed the patients, who were
Read More

Zicam Defective Drug Recall Begins

  • July 23, 2009
  • Defective Products & Drugs
  • 0 Comments
Matrixx Initiatives is issuing a product recall of several Zicam intranasal cold remedies a week after federal regulators told the company to stop selling its products that were apparently causing consumers to lose their sense of smell. According to a Reuters news report, the U.S. Food and Drug Administration (FDA) recently issued a warning to
Read More

Maryland Patients Can Sue Drug Makers: Supreme Court Ruling

  • March 5, 2009
  • Defective Products & Drugs
  • 0 Comments
The Baltimore Sun reports in a story that a Supreme Court ruling upholds the right for patients to sue drug manufacturers. According to the Sun, the Bush administration made a push in its final days to shield drug manufacturers from personal injury claims. The pro-manufacturer strategy claimed that FDA approval of a given drug removed
Read More